have demonstrated that adoptive autologous T cells (CD8+ T cells account for more than 2/3) transduced by T cell receptor (TCR) targeting NY-ESO-1 can mediate tumor regression in patients with metastatic melanoma and synovial cell sarcoma, with response rates of 45% and 67% respectively (25). The gene discussed is CD8A; the disease is neoplasm.